Loading organizations...
§ Private Profile · Montréal, Québec
Virtual sleep clinic offering CBT for insomnia and sleep disorders to employers for employee well-being and productivity.
HALEO Clinic, based in Montreal, Quebec, Canada, operates a virtual sleep clinic that delivers clinically proven treatments for insomnia and sleep disorders through a mobile application. The clinic utilizes licensed therapists and AI-supported personalized protocols, such as cognitive behavioral therapy, to improve patient outcomes, primarily targeting corporate employers in the US and Canada. It boasts over 30 registered therapists and reports that 94% of program participants no longer experience clinically significant insomnia symptoms. The company has secured cumulative seed funding of $6.5 million CAD, with investors including Boréal Ventures, AQC Capital, Investissement Québec, Desjardins Capital, and Real Ventures. Green Shield Canada is a key partner, and René Beaudoin was recently appointed to its board of directors. HALEO Clinic was founded in 2015 by Bradley Smith.
HALEO Clinic has raised $4.0M across 1 funding round.
HALEO Clinic has raised $4.0M in total across 1 funding round.
HALEO Clinic has raised $4.0M in total across 1 funding round.
HALEO Clinic's investors include Boreal Ventures, Kalthoum Bouacida, Anges Québec, Desjardins Capital, Investissement Québec, MEDTEQ+, Real Ventures.
HALEO Clinic has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in July 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 1, 2022 | $4M Seed | Boreal Ventures, Kalthoum Bouacida | Anges Québec, Desjardins Capital, Investissement Québec, MEDTEQ+, Real Ventures | Announced |
HALEO Clinic is a Montreal-based virtual sleep clinic that delivers evidence-based, clinically-proven programs via a SaaS mobile application to combat insomnia and poor sleep, primarily targeting organizations to enhance employee health, productivity, and reduce costs like absenteeism and disability leave[1][2][3][4][5]. It serves employers across North America with tailored prevention and disability management pathways using cognitive behavioral therapy for insomnia (CBT-I), achieving results in as little as three weeks and delivering up to 10x ROI through lower medication use, fewer workplace incidents, and faster returns to work[3][4]. With around 56 employees and revenue under $5 million, HALEO has shown growth momentum via a $5.2 million CAD seed-extension round in 2022 and expansion into the U.S. market[2][3].
Founded in 2015, HALEO emerged as North America's first provider of virtual sleep programs, starting with the launch of its first virtual CBT-I protocol in 2016, administered through meetings with sleep experts[2][3]. The company quickly gained traction in 2017 by securing its inaugural corporate client—a major Canadian financial institution offering programs to 57,000 employees—and continued milestones include presenting clinical outcomes at SLEEP 2019, launching a sleep optimization protocol for the public in 2020, U.S. market entry in 2021, $5.2 million financing in 2022, and disclosing research at the 2023 Canadian Sleep Society Conference[3]. While specific founder details are not detailed in available sources, HALEO's evolution reflects a pivot from individual care to enterprise-focused solutions, helping thousands overcome sleep issues[2][3].
HALEO rides the wave of digital health and telehealth expansion, particularly in mental health and workplace wellness, accelerated by post-pandemic awareness of sleep's role in productivity amid rising burnout and remote/hybrid work challenges[3][4]. Timing aligns with growing employer demands for ROI-driven employee assistance programs (EAPs), as poor sleep contributes to billions in annual losses from errors, injuries, and disability—market forces favoring SaaS solutions like HALEO's that integrate seamlessly into HR systems[4][5]. It influences the ecosystem by pioneering virtual CBT-I at scale, presenting research at top conferences, and proving clinically-validated tech can outperform traditional care, paving the way for sleep tech in corporate health stacks[3].
HALEO is poised for accelerated U.S. expansion post-2022 funding, potentially deepening enterprise partnerships and launching AI-enhanced personalization or broader wellness integrations amid surging demand for sleep optimization in high-stress sectors like finance and shift work[3]. Trends like AI-driven health monitoring and mandated corporate wellness will shape its path, amplifying influence as sleep tech matures into a standard HR tool. This positions HALEO to transform how organizations tackle the hidden costs of poor sleep, building on its clinical edge for sustained growth.